{"organizations": [], "uuid": "49e767b3e3561b31257dd9f794341efa4d8c5a3c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-ionis-reports-q1-total-revenue-of/brief-ionis-reports-q1-total-revenue-of-144-mln-vs-116-mln-idUSASC09ZW2", "country": "US", "domain_rank": 408, "title": "BRIEF-Ionis Reports Q1 Total Revenue Of $144 Mln Vs $116 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-04T14:10:00.000+03:00", "replies_count": 0, "uuid": "49e767b3e3561b31257dd9f794341efa4d8c5a3c"}, "author": "", "url": "https://www.reuters.com/article/brief-ionis-reports-q1-total-revenue-of/brief-ionis-reports-q1-total-revenue-of-144-mln-vs-116-mln-idUSASC09ZW2", "ord_in_thread": 0, "title": "BRIEF-Ionis Reports Q1 Total Revenue Of $144 Mln Vs $116 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "ionis pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 4, 2018 / 11:11 AM / in 5 minutes BRIEF-Ionis Reports Q1 Total Revenue Of $144 Mln Vs $116 Mln Reuters Staff\nMay 4 (Reuters) - Ionis Pharmaceuticals Inc: * QTRLY TOTAL REVENUE $144 MILLION VERSUS $116 MILLION\n* FOR Q1 OF 2018, BASIC AND DILUTED NET LOSS PER SHARE WERE $0.01 Source text for Eikon: ", "external_links": [], "published": "2018-05-04T14:10:00.000+03:00", "crawled": "2018-05-04T14:23:23.006+03:00", "highlightTitle": ""}